Search Results
Alzheimer Europe Conference, Angela Hodges, PHAGO - Targeting TREM2 & CD33 for treatment of AD
TREM2-targeted antibodies enhance microglial function in Alzheimer’s disease model
TREM2, a new marker of Alzheimer's disease
Therapeutic targeting of TREM2 in Alzheimer’s disease
TREM2, Apolipoproteins, and Alzheimer’s Disease
TREM2 in Neurodegeneration and Cancer | Marco Colonna, MD
A next-generation CD33-directed ADC for AML
Alzheimers Disease Could be Inhibited by Protein CD33
Dive into the Alzheimer's Disease: 3D Visualisation of TREM2
Future research directions for neuropsychiatric symptoms in Alzheimer's disease
Harnessing T-cells in acute leukemia and an anti-CD33/CD3 BiTE antibody
Elizabeth Head, MA, PhD - TDP-43 pathology in Down Syndrome and Alzheimer Disease